Nikita Gupta, Mohd Naveed Khan, Varda Farooqui, Guntoju Poojitha & Thipparam Kavya·Asian Journal of Immunology·2024
Vadadustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor, may offer an oral alternative to injectable erythropoiesis-stimulating agents (ESAs) to treat anemia in patients undergoing peritoneal dialysis. Current standard of care for anemia linked to chronic kidney disea...
Open access
Research Article10.9734/aji/2024/v7i1153
Nikita Gupta, Sana Begum, Varda Farooqui, Summaiya Afreen & Pranitha Avunoori·Asian Journal of Immunology·2024
Iguratimod is a small novel compound considered as a disease-modifying anti-rheumatic drug (DMARD), which exhibits anti-inflammatory and immunomodulatory effects. Iguratimod acts directly on B cells by inhibiting the production of inflammatory cytokines (tumor necrosis factor-α,...
Open access
Research Article10.9734/aji/2024/v7i1132
Alzheimer's disease is a progressive neurological disorder that primarily affects older adults and is the most common cause of dementia. It involves the degeneration of brain cells, leading to memory loss, cognitive decline, and changes in behavior and personality. Worldwide, an...
Open access
Research Article10.9734/indj/2025/v22i3476